Twice-per-weekSelinexor, 2 Days Melphalan
Twice-per-weekSelinexor, 2 Days Melphalan
Not yet recruiting · NCT06613035 · Registry updated 2024-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Twice-per-weekSelinexor, 2 Days Melphalan | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Phase 3 | 2024-09-25 | NCT06613035 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hebei Medical University Second Hospital | Shijiazhuang | China | 1 |
| People's Liberation Army The General Hospital of Western Theater Command | Chengdu | China | 3 |
| The 960th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army | Jinan | China | 3 |
| Zhengzhou University First Affiliated Hospital | Zhengzhou | China | 3 |